Trials / Conditions / Hypercalcemia of Malignancy

Hypercalcemia of Malignancy

8 registered clinical trials studyying Hypercalcemia of Malignancy.

Status	Trial	Sponsor	Phase
Unknown	A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM NCT04198480	Shanghai JMT-Bio Inc.	Phase 1 / Phase 2
Withdrawn	One Week Comparison Study of PTH and PTHrP Infusions NCT01333267	University of Pittsburgh	Phase 1
Completed	Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium NCT00896454	Amgen	Phase 2
Withdrawn	S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spr NCT00301886	SWOG Cancer Research Network	Phase 3
Terminated	Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the NCT00458796	University of Leeds	N/A
Unknown	Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer NCT00326820	Wales Cancer Trials Unit	Phase 3
Completed	Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases NCT00060138	Chugai Pharmaceutical	Phase 1 / Phase 2
Completed	Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone NCT00003884	Novartis	Phase 3